Intro and Agenda.
Choose your embed type above, then paste the code on your website.
CyTOF Summit on demand - Igniting Insight into Immuno-Oncology | 14 Jun 2022
Cutting Edge Cytometry and Clinical Trials: A Case Study | Caroline Roe, MLI
Method validation studies using the Maxpar® Direct™ Immune Profiling Assay™ | Sasidhar Vemula, PhD
Efficient, High-Content Immune Profiling with CyTOF® XT and MDIPA | Vinicius Motta, PhD
Single-Cell Immune Profiling Can Help Resolve Tumor Microenvironment Complexities | GEN
Sample Multiplexing in Suspension Mass Cytometry with Easy Cell Barcoding
Introducing CyTOF® XT and Maxpar™ Direct™ Assays for efficient high-content immune profiling
Mass Cytometry for Precision Medicine | Petter Brodin, MD, PhD
Leveraging CyTOF to track cancer vaccine induced T cell responses for up to 20 years | Erika Crosby
Profiling three layers of human immunity with CyTOF®, Olink® and automated RNA-seq
CyTOF in the Cancer Immune Monitoring and Analysis Centers (CIMAC) | Holden Maecker, PhD
A Universal 10-Tube Titration Strategy for Mass Cytometry Panels | Vinicius Motta, PhD